tiprankstipranks
L&C BIO Co., Ltd. (KR:290650)
:290650
South Korea Market
290650
L&C BIO Co., Ltd.
RESEARCH TOOLSreports

L&C BIO Co., Ltd. (290650) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

290650 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
L&C
BIO Co., Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

290650 Stock 12 Month Forecast

There Are No Analyst Ratings for KR:290650 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

290650 Financial Forecast

290650 Earnings Forecast

Next quarter’s earnings estimate for 290650 is ₩260.75 with a range of ₩260.75 to ₩260.75. The previous quarter’s EPS was ₩140.94. 290650 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.38% of the time in the same period. In the last calendar year 290650 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 290650 is ₩260.75 with a range of ₩260.75 to ₩260.75. The previous quarter’s EPS was ₩140.94. 290650 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.38% of the time in the same period. In the last calendar year 290650 has Performed in-line its overall industry.

290650 Sales Forecast

Next quarter’s sales forecast for 290650 is ₩45.30B with a range of ₩42.10B to ₩48.50B. The previous quarter’s sales results were ₩38.78B. 290650 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.34% of the time in the same period. In the last calendar year 290650 has Performed in-line its overall industry.
Next quarter’s sales forecast for 290650 is ₩45.30B with a range of ₩42.10B to ₩48.50B. The previous quarter’s sales results were ₩38.78B. 290650 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.34% of the time in the same period. In the last calendar year 290650 has Performed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the General Sector
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

290650 Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

290650 Stock Forecast FAQ

What is KR:290650’s average 12-month price target, according to analysts?
Currently, no data Available
What is KR:290650’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for KR:290650, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is L&C BIO Co., Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is L&C BIO Co., Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about L&C BIO Co., Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of L&C BIO Co., Ltd.?
      To buy shares of KR:290650, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.